Compugen (CGEN) Cost of Revenue (2010 - 2026)

Compugen (CGEN) has 14 years of Cost of Revenue data on file, last reported at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 24.0% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (up 5.43% YoY), and the FY2025 full-year result was $9.3 million, up 16.66% from the prior year.
• Cost of Revenue slipped to $1.8 million in Q1 2026, from $3.5 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.6 million in Q3 2024 to a low of $675000.0 in Q4 2024.
• A 5-year average of $2.0 million and a median of $1.8 million in 2026 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue plunged 66.32% in 2024 and soared 423.85% in 2025, its largest moves.
• Tracing CGEN's Cost of Revenue over 5 years: stood at $975000.0 in 2022, then jumped by 105.54% to $2.0 million in 2023, then sank by 66.32% to $675000.0 in 2024, then soared by 423.85% to $3.5 million in 2025, then sank by 48.42% to $1.8 million in 2026.
• Business Quant data shows CGEN's Cost of Revenue at $1.8 million in Q1 2026, $3.5 million in Q4 2025, and $1.6 million in Q3 2025.